AptarGroup, Inc. (ATR): Short-Term Debt to Equity

AptarGroup, Inc. (ATR) integrates its unique sprayers into premium cosmetics and medications for global brands. Growth is driven by exclusive pump agreements and the pharmaceutical industry's transition to non-aerosol systems. The history of the short-term debt-to-equity ratio demonstrates that the current level equals 0.14, which is critical given the dependence on polymer prices and demand within the pharmaceutical sector.

The short-term debt-to-equity ratio compares liabilities maturing within one year to total shareholder equity to assess the current financial burden. For AptarGroup, Inc. (ATR), a steady order flow in the pharmaceutical sector ensures liquidity, minimizing reliance on short-term borrowings. The historical trend of the short-term debt-to-equity ratio confirms the absence of sharp spikes in credit pressure. This price action reflects conservative liability management and a high-quality balance sheet structure.